Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
38,844,993
-
Share change
-
+3,562,504
-
Total reported value
-
$46,983,012
-
Put/Call ratio
-
70%
-
Price per share
-
$1.21
-
Number of holders
-
74
-
Value change
-
+$4,282,053
-
Number of buys
-
27
-
Number of sells
-
30
Institutional Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q1 2017
As of 31 Mar 2017,
TRANSENTERIX INC - COM NEW (TRXC) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,844,993 shares.
The largest 10 holders included
Aisling Capital LLC, SV Health Investors, LLC, JPMORGAN CHASE & CO, BlackRock Inc., StepStone Group LP, VANGUARD GROUP INC, MASTERS CAPITAL MANAGEMENT LLC, STATE STREET CORP, INTERNATIONAL BIOTECHNOLOGY TRUST PLC, and NORTHERN TRUST CORP.
This page lists
74
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.